232 related articles for article (PubMed ID: 30161122)
1. Antihyperglycemic drugs use and new-onset atrial fibrillation: A population-based nested case control study.
Liou YS; Yang FY; Chen HY; Jong GP
PLoS One; 2018; 13(8):e0197245. PubMed ID: 30161122
[TBL] [Abstract][Full Text] [Related]
2. Antihyperglycemic drugs use and new-onset atrial fibrillation in elderly patients.
Chen HY; Yang FY; Jong GP; Liou YS
Eur J Clin Invest; 2017 May; 47(5):388-393. PubMed ID: 28369870
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan.
Chang CY; Yeh YH; Chan YH; Liu JR; Chang SH; Lee HF; Wu LS; Yen KC; Kuo CT; See LC
Cardiovasc Diabetol; 2017 Dec; 16(1):159. PubMed ID: 29258504
[TBL] [Abstract][Full Text] [Related]
4. Atrial fibrillation and type 2 diabetes: Prevalence, etiology, pathophysiology and effect of anti-diabetic therapies.
Bell DSH; Goncalves E
Diabetes Obes Metab; 2019 Feb; 21(2):210-217. PubMed ID: 30144274
[TBL] [Abstract][Full Text] [Related]
5. Association between use of oral-antidiabetic drugs and the risk of aortic aneurysm: a nested case-control analysis.
Hsu CY; Su YW; Chen YT; Tsai SH; Chang CC; Li SY; Huang PH; Chen JW; Lin SJ
Cardiovasc Diabetol; 2016 Sep; 15(1):125. PubMed ID: 27585542
[TBL] [Abstract][Full Text] [Related]
6. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
Ou HT; Chang KC; Li CY; Wu JS
Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
[TBL] [Abstract][Full Text] [Related]
7. Overview of Data Concerning the Safe Use of Antihyperglycemic Medications in Type 2 Diabetes Mellitus and Chronic Kidney Disease.
Roussel R; Lorraine J; Rodriguez A; Salaun-Martin C
Adv Ther; 2015 Nov; 32(11):1029-64. PubMed ID: 26581749
[TBL] [Abstract][Full Text] [Related]
8. Endothelial Dysfunction, Fibrinolytic Activity, and Coagulation Activity in Patients With Atrial Fibrillation According to Type II Diabetes Mellitus Status.
Patti G; Cerchiara E; Bressi E; Giannetti B; Veneri AD; Di Sciascio G; Avvisati G; De Caterina R
Am J Cardiol; 2020 Mar; 125(5):751-758. PubMed ID: 31889526
[TBL] [Abstract][Full Text] [Related]
9. Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus.
Ou SM; Shih CJ; Chao PW; Chu H; Kuo SC; Lee YJ; Wang SJ; Yang CY; Lin CC; Chen TJ; Tarng DC; Li SY; Chen YT
Ann Intern Med; 2015 Nov; 163(9):663-72. PubMed ID: 26457538
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Different Case-Crossover Variants in Handling Exposure-Time Trend or Persistent-User Bias: Using Dipeptidyl Peptidase-4 Inhibitors and the Risk of Heart Failure as an Example.
Dong YH; Wang SV; Gagne JJ; Wu LC; Chang CH
Value Health; 2020 Feb; 23(2):217-226. PubMed ID: 32113627
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular events associated with second-line anti-diabetes treatments: analysis of real-world Korean data.
Ha KH; Kim B; Choi H; Kim DJ; Kim HC
Diabet Med; 2017 Sep; 34(9):1235-1243. PubMed ID: 28523719
[TBL] [Abstract][Full Text] [Related]
12. Long-term effect of antihypertensive drugs on the risk of new-onset atrial fibrillation: a longitudinal cohort study.
Jong GP; Chen HY; Li SY; Liou YS
Hypertens Res; 2014 Oct; 37(10):950-3. PubMed ID: 24965171
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of dialysis in patients with chronic kidney disease and new-onset atrial fibrillation: A population-based cohort study.
Hung TW; Huang JY; Jong GP
PLoS One; 2019; 14(9):e0222656. PubMed ID: 31536566
[TBL] [Abstract][Full Text] [Related]
14. Changes in Antidiabetic Drug Prescription and Glycemic Control Trends in Elderly Patients with Type 2 Diabetes Mellitus from 2005-2013: An Analysis of the National Center Diabetes Database (NCDD-03).
Yamamoto-Honda R; Takahashi Y; Mori Y; Yamashita S; Yoshida Y; Kawazu S; Iwamoto Y; Kajio H; Yanai H; Mishima S; Handa N; Shimokawa K; Yoshida A; Watanabe H; Ohe K; Shimbo T; Noda M
Intern Med; 2018 May; 57(9):1229-1240. PubMed ID: 29279487
[TBL] [Abstract][Full Text] [Related]
15. Association Between Use of Dipeptidyl Peptidase-4 Inhibitors and the Risk of Acute Kidney Injury: A Nested Case-Control Study.
Shih CJ; Lee YJ; Lo YH; Kuo SC; Ou SM; Chen YT
Mayo Clin Proc; 2016 Jul; 91(7):867-72. PubMed ID: 27236426
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan.
Chiu CC; Huang CC; Chen YC; Chen TJ; Liang Y; Lin SJ; Chen JW; Leu HB; Chan WL
Intern Med; 2013; 52(9):939-46. PubMed ID: 23648711
[TBL] [Abstract][Full Text] [Related]
17. Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes.
Inzucchi SE
Endocrinol Metab Clin North Am; 2007 Dec; 36 Suppl 2 Incretin():2-17. PubMed ID: 18405144
[No Abstract] [Full Text] [Related]
18. Effects of Basal Insulin on Lipid Profile Compared to Other Classes of Antihyperglycemic Agents in Type 2 Diabetic Patients.
Rigato M; Avogaro A; Vigili de Kreutzenberg S; Fadini GP
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32271381
[TBL] [Abstract][Full Text] [Related]
19. Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes.
Thomsen RW; Baggesen LM; Søgaard M; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
Diabetologia; 2015 Oct; 58(10):2247-53. PubMed ID: 26277380
[TBL] [Abstract][Full Text] [Related]
20. Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database.
Fadini GP; Avogaro A; Degli Esposti L; Russo P; Saragoni S; Buda S; Rosano G; Pecorelli S; Pani L;
Eur Heart J; 2015 Sep; 36(36):2454-62. PubMed ID: 26112890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
